Katie Little, RN, BSN, AS, OCN, is nurse manager at Inova Schar Cancer. At Fairfax West, one of five infusion centers in the Inova system, she and her team faced a familiar challenge for infusion leaders: how to expand hours…
Vedant Bhosale
The ability to identify patients at increased risk for hereditary cancer has never been more achievable, yet it’s still far from routine. National guidelines and accreditation programs call for proactive risk assessment and genetic testing. Still, many patients who meet…
Imagine a future where some cancers are caught before symptoms appear, before they spread, before lives are disrupted. That’s the potential of multi-cancer early detection (MCED), a transformative approach that’s reshaping how healthcare leaders think about cancer screening. In 2025 alone,…
About 40% of people will be diagnosed with cancer in their lifetime.1 Unfortunately, many diagnoses are made when cancer has progressed to an advanced stage2 — when treatment is often less effective and the cost of care is higher.3, 4